Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

Update Il y a 5 ans
Reference: NCT01494857

Woman and Man

  • | Country :
  • Israel
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to assess the clinical benefit and tolerability of adalimumab, a fully human monoclonal antibody to tumor necrosis factor α (TNF- α), in patients with ulcerative colitis (UC) naive to treatment with biologics.


Inclusion criteria

  • Ulcerative colitis

Links